Agreed. The fools with the negative posts about pay and leadership are out of touch with what is truly going on at this company, and also do not understand the high risk high reward nature of the Biotech pharma industry. Anybody who looks beyond 3 years in a biotech company needs to go back to big traditional pharma and die on the vine there; the reality is Lundbeck is structured to survive in this industry and has a very good outlook in the near term....notice your bonus is pretty good these past few years? TG is the right person at the right time for this company, and if things go his way on the BD front (which so far they are), we are looking at some of the best leadership I have seen in this industry.